Quest Diagnostics Incorporated (BMV:DGX)
Mexico flag Mexico · Delayed Price · Currency is MXN
3,430.00
+37.30 (1.10%)
At close: Sep 23, 2025
1.10%
Market Cap387.91B
Revenue (ttm)198.43B
Net Income (ttm)17.82B
Shares Outn/a
EPS (ttm)157.40
PE Ratio21.77
Forward PE18.45
Dividend61.55 (1.79%)
Ex-Dividend DateJul 7, 2025
Volume15
Average Volume770
Open3,430.00
Previous Close3,392.70
Day's Range3,430.00 - 3,430.00
52-Week Range2,844.15 - 3,430.00
Betan/a
RSI61.19
Earnings DateOct 22, 2025

About Quest Diagnostics

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans,... [Read more]

Industry Medical Laboratories
Founded 1967
Employees 56,000
Stock Exchange Mexican Stock Exchange
Ticker Symbol DGX
Full Company Profile

Financial Performance

In 2024, Quest Diagnostics's revenue was $9.87 billion, an increase of 6.70% compared to the previous year's $9.25 billion. Earnings were $866.00 million, an increase of 1.88%.

Financial numbers in USD Financial Statements

News

There is no news available yet.